| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 13.624 | 16.471 | 15.224 |
| Total Income - EUR | - | - | - | - | - | - | - | 13.831 | 16.878 | 15.295 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 1.869 | 6.626 | 3.924 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 11.962 | 10.253 | 11.372 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 11.638 | 9.998 | 9.814 |
| Employees | - | - | - | - | - | - | - | 0 | 1 | 0 |
Check the financial reports for the company - Torontoimplantsystemlab S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | - | - | 12.489 | 17.482 | 29.268 |
| Inventories | - | - | - | - | - | - | - | 0 | 89 | 0 |
| Receivables | - | - | - | - | - | - | - | 11.415 | 16.759 | 27.993 |
| Cash | - | - | - | - | - | - | - | 1.074 | 633 | 1.275 |
| Shareholders Funds | - | - | - | - | - | - | - | 11.679 | 15.058 | 24.788 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 810 | 2.424 | 4.480 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Torontoimplantsystemlab S.r.l.